News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
EXCLUSIVE: DelMar Pharmaceuticals CEO Outlines 2015 Plans, Looks to Clinical Cancer Trials     2/27/2015
Rigel (RIGL) Lands $339 Million+ Cancer Deal With Bristol-Myers Squibb (BMY)     2/24/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival     2/5/2015
EXCLUSIVE: Eli Lilly (LLY) Exec Tells BioSpace (DHX) New Cancer Tool Could Be "Historic"     1/30/2015
Curis, Inc. (CRIS), Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact     1/22/2015
Pfizer (PFE) Plots Path Outside of Melanoma in Bid to Join Cancer Race     1/19/2015
Pfizer (PFE)'s New Type of Cancer Drug May Get Early Approval: Analysts     1/14/2015
J.P. Morgan: Express Scripts Inc. CEO Said it Will Take On Cancer Drug Pricing Next     1/13/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process     1/12/2015
Incyte Corporation (INCY), Agenus (AGEN) Strike $410 Million+ Immuno-Oncology Antibodies Pact     1/9/2015
Oncothyreon Inc. (ONTY) Strikes $300 Million Cancer Pact With Array BioPharma, Inc. (ARRY)     12/15/2014
Bayer AG (BAYZF) Loses Battle To Block Generic Cancer Drug In India's Top Court     12/15/2014
Pfizer (PFE) Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal     12/9/2014
Evgen Pharma Will Float £20M IPO To Fund Cancer Drug Trials     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014

News from Around the Web
Olive Oil Compound Kills Cancer In Minutes, Rutgers University Reveals     2/24/2015
Flame Retardants Used In Couches May Cause Metabolic, Liver Problems, University of New Hampshire Reveals     2/23/2015
Popular Soda Ingredient Poses Cancer Risk To Consumers, Johns Hopkins University Reveals     2/20/2015
Go Green: 6 Surprising Health Benefits Of Green Tea     2/20/2015
A New Weapon In The Fight Against Cancer, Concordia University Reveals     2/20/2015
Drinking Coffee May Lower Endometrial Cancer Risk, Imperial College London Study     2/9/2015
"Half Of UK People" Will Get Cancer     2/4/2015
How Drinking Green Tea Can Kill Cancer Cells, Penn State University Study     2/4/2015
Schoolgirl Comment Points To Antibiotics As New Cancer Treatments, University of Manchester Study     1/29/2015
Broccoli Compound May Treat Prostate Cancer, Texas A&M Health Science Center Study     1/22/2015
Sitting Too Much? Even Exercise May Not Save You, University Health Network Study     1/21/2015
How Vitamin D May Fight Colorectal Cancer, Dana-Farber Cancer Institute Study     1/16/2015
Unhealthy Insulin Levels May Boost Breast Cancer Risk, Imperial College London Study     1/16/2015
Stroke Risk Spikes After New Cancer Diagnoses, Weill Cornell Medical College Study     1/9/2015
Most Cancer Are Caused By Bad Luck, Johns Hopkins Kimmel Cancer Center Study Shows     1/5/2015

Press Releases
Almac Discovery Initiates Phase 1 Study Of ALM201 For The Treatment Of Patients With Advanced Ovarian Cancer And Other Solid Tumours     3/2/2015
Kite Pharma (KITE) Expands Its Research And Development Collaboration With The National Cancer Institute To Develop A Next Generation Of Cancer Immunotherapy Products For Solid Tumors     3/2/2015
European Medicines Agency Release: Novartis AG (NVS)'s Zykadia Recommended For Approval In Advanced Non Small Cell Lung Cancer     2/27/2015
Agilent Technologies Inc. (A) Introduces Two Innovative Products To Advance Clinical Cancer Research     2/26/2015
Caris Life Sciences' Multiplatform Tumor Profiling Helps To Identify Potential Predictive Biomarkers In Renal Cell Carcinoma     2/26/2015
Nodality, Inc. Presents Data From Immuno-Oncology Program Applying Company‚Äôs Novel Single Cell Network Profiling (SCNP) Platform     2/25/2015
CryoPort, Inc. Provides Logistics Solution And Services For Kite Pharma (KITE)'s Lead Clinical Program In Cancer Immunotherapy     2/24/2015
Progenics Pharmaceuticals, Inc. (PGNX) To Present Full Phase 2 Data For PSMA ADC At The 2015 American Society of Clinical Oncology GU Symposium     2/24/2015
NovoCure Ltd. Enrolls The First Patient In Its Phase II STELLAR Trial Of Tumor Treating Fields Together With Pemetrexed And Cisplatin Or Carboplatin For The Treatment Of Malignant Mesothelioma     2/23/2015
NYU Langone Medical Center, Technion-Israel Institute Of Technology To Forge Groundbreaking Partnership In Cancer Research     2/18/2015
VBL Therapeutics (VBLX) Announces Removal Of FDA Partial Clinical Hold On VB-111     2/17/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China     2/16/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs     2/11/2015
Biothera Immunotherapy Binds To Multiple Immune Cell Receptors To Kill Cancer     2/10/2015
Galena Biopharma  (GALE) Enrolls 700th Patient In Neuvax (Nelipepimut-S) Phase 3 PRESENT Clinical Trial     2/9/2015